Cita APA (7a ed.)
Pagnano, K. B. B., Miranda, E. C., Delamain, M. T., Duarte, G. O., de Paula, E. V., Lorand-Metze, I., & de Souza, C. A. (2017). Influence of BCR-ABL Transcript Type on Outcome in Patients With Chronic-Phase Chronic Myeloid Leukemia Treated With Imatinib. Clinical Lymphoma, Myeloma & Leukemia, 17(11), 728-734.
Cita Chicago Style (17a ed.)
Pagnano, Katia Borgia Barbosa, Eliana Cristina Miranda, Márcia Torresan Delamain, Gislaine Oliveira Duarte, Erich Vinicius de Paula, Irene Lorand-Metze, y Carmino Antonio de Souza. "Influence of BCR-ABL Transcript Type on Outcome in Patients With Chronic-Phase Chronic Myeloid Leukemia Treated With Imatinib." Clinical Lymphoma, Myeloma & Leukemia 17, no. 11 (2017): 728-734.
Cita MLA (9a ed.)
Pagnano, Katia Borgia Barbosa, et al. "Influence of BCR-ABL Transcript Type on Outcome in Patients With Chronic-Phase Chronic Myeloid Leukemia Treated With Imatinib." Clinical Lymphoma, Myeloma & Leukemia, vol. 17, no. 11, 2017, pp. 728-734.
Precaución: Estas citas no son 100% exactas.